…
comment: The repository administrator has not yet configured an RDF license.
primary topic: THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES

THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES
type: AcademicArticle
type: Article
abstract: Endometrial cancer is one of the most common gynecological malignancies worldwide, with its incidence closely associated with metabolic disorders. Metabolic syndrome, characterized by obesity, insulin resistance, dyslipidemia, and hypertension, has been identified as a significant risk factor influencing the development, progression, and prognosis of endometrial cancer. This article examines the impact of metabolic syndrome on the clinical course and outcomes of endometrial cancer, focusing on underlying biochemical mechanisms and current therapeutic approaches. Evidence suggests that metabolic syndrome contributes to tumor progression through hormonal imbalance, chronic inflammation, and altered metabolic signaling pathways. Understanding these interactions is essential for improving prognosis and developing individualized treatment strategies for patients with endometrial cancer.
date: 2026-02-07
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository

South Aral Region Medical Journal
type: Organization

South Aral Region Medical Journal
type: Collection

Maftuna Akbarova
type: Person
given name: Maftuna
family name: Akbarova

HTML Summary of #52081 THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES
format: text/html
primary topic: THE IMPACT OF METABOLIC SYNDROME ON THE PROGNOSIS AND COURSE OF ENDOMETRIAL CANCER: CLINICAL, BIOCHEMICAL ASPECTS AND THERAPEUTIC APPROACHES